Stockscreener 앱 받기
5.735
1.87%
0.105
Exagen Inc 주식(XGN)의 최신 뉴스
Exagen (XGN) Maintains 'Buy' Rating as Price Target Rises | XGN Stock News - GuruFocus
Exagen (XGN) Receives Increased Price Target from Canaccord | XG - GuruFocus
Exagen prices public offering of common stock - MSN
Exagen Inc. (NASDAQ:XGN) Q1 2025 Earnings Call Transcript - Insider Monkey
Exagen Inc. Announces Closing of $20.2 Million Public - GlobeNewswire
Exagen Inc. anticipates $65M revenue for 2025 amid ASP growth and new biomarker launches - MSN
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares | XGN Stock News - GuruFocus
Exagen Inc. Completes Additional Public Offering of 502,500 Shares, Raising Approximately $20.2 Million - Nasdaq
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of ... - Bluefield Daily Telegraph
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares - Stock Titan
Earnings Update: Here's Why Analysts Just Lifted Their Exagen Inc. (NASDAQ:XGN) Price Target To US$7.75 - simplywall.st
Exagen Inc (XGN)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX
Exagen sets price for public stock offering at $5.25 per share - Investing.com Nigeria
William Blair Issues Pessimistic Outlook for Exagen Earnings - Defense World
Exagen prices 3.35M shares at $5.25 per share in public offering - TipRanks
Exagen Prices $17.6 Million Public Offering; Shares Down - marketscreener.com
Exagen Inc. Prices Public Offering Of Common Stock At $5.25 Per Share - marketscreener.com
Exagen (XGN) Sets Price for Public Offering of Common Shares | XGN Stock News - GuruFocus
Exagen First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Exagen Inc. Prices Public Offering of Common Stock | XGN Stock News - GuruFocus
Exagen Inc. Prices Public Offering of Common Stock - Bluefield Daily Telegraph
William Blair Estimates Exagen’s Q1 Earnings (NASDAQ:XGN) - Defense World
Exagen announces common stock offering, no amount given - TipRanks
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates - MSN
Exagen (XGN) Announces Public Offering of Common Stock | XGN Stock News - GuruFocus
Exagen Inc. Announces Proposed Public Offering of Common Stock - The Manila Times
Exagen price target raised to $9 from $5 at BTIG - TipRanks
Exagen (XGN) Sees Price Target Increase Following Strong Q1 Performance | XGN Stock News - GuruFocus
Marshall Wace LLP Acquires Shares of 16,048 Exagen Inc. (NASDAQ:XGN) - Defense World
KeyBanc maintains Exagen stock at Sector Weight By Investing.com - Investing.com Nigeria
KeyBanc maintains Exagen stock at Sector Weight - Investing.com
Exagen Inc (XGN) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Wins Amidst ... - Yahoo Finance
Earnings call transcript: Exagen Inc. Q1 2025 revenue beats forecasts, stock dips - Investing.com Nigeria
Exagen Inc (XGN) Q1 2025 Earnings Call Highlights: Revenue Growt - GuruFocus
Exagen Inc. Reports Record Revenue Amid Strategic Growth - TipRanks
Exagen Inc. Earnings Call Highlights Record Growth - TipRanks
Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in A - GuruFocus
Exagen Inc (XGN) Q1 2025 Earnings: Revenue Surpasses Estimates a - GuruFocus
Exagen Inc reports results for the quarter ended March 31Earnings Summary - TradingView
EXAGEN INC. SEC 10-Q Report - TradingView
Exagen Inc (XGN) Q1 2025 Earnings: Revenue Surpasses Estimates at $15.5M, EPS Matches Expectations at -$0.20 - GuruFocus
XGN Projects Revenue Growth and Positive EBITDA by 2025 | XGN St - GuruFocus
Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume - The Manila Times
Exagen Inc. Reports Record Q1 2025 Revenue - TradingView
Exagen Q1 Earnings: Record $15.5M Revenue as New Lupus Test Launch Sparks Growth Path to Profitability - Stock Titan
Exagen earnings beat by $0.02, revenue topped estimates - Investing.com
Geode Capital Management LLC Grows Holdings in Exagen Inc. (NASDAQ:XGN) - Defense World
1.16%
자본화:
|
볼륨(24시간):